Karyopharm Therapeutics (KPTI) Moves 27.9% Higher: Will This Strength Last?

Karyopharm Therapeutics (KPTI) shares rallied 27.9% in the last trading session to close at $7.48. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 7.3% loss over the past four weeks.The sudden gain in the stock price can be attributed to a positive investor mindset regarding the continued strong uptake of Karyopharm Therapeutics’ only marketed product, Xpovio (selinexor), approved for multiple myeloma and B-c ...